IPAS770
Concessão de registro em designação
RPI 2890
26/05/2026
Voltar para busca
Dado oficial do INPI
TGX
Sabia que essa marca já está registrada no Brasil?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Registro de marca em vigor (Madri)Tipo: VerbalEscritório: Brasil
Andamento no INPI
- Depósito31/01/25
- Publicação22/07/25
- Exame
- Deferimento12/05/26
- Concessão
- Vigente31/01/35
Registro concedido e em vigor até 31/01/2035, quando precisa ser renovado.
Proteção válida até:31/01/2035
Última movimentação publicada pelo INPI: 26/05/2026. Atualizamos a cada nova RPI, publicada semanalmente.
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação INPI
Registro de marca em vigor (Madri)
Tipo de processo
Pedido de registro
Eventos registrados
3
Atualização mais recente
26/05/2026
Tipo de marca
Verbal
Classes Nice
5, 9
Data de depósito
31/01/2025
Data de registro
-
Data de expiração
31/01/2035
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Natureza
Madri Produto/Serviço
Escritório responsável
Brasil
Tipo de titular
NÃO RESIDENTE
Localização do titular
GB
Titulares e representantes
Titulares
Trogenix Ltd
Representantes
Sem dados de representantes.
Classificação técnica
Classes Nice
Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical, medical or veterinary preparations and substancespharmaceutical preparations for use in targeted pharmaceutical therapiespharmaceutical preparations and products for the treatment of neoplastic diseasespharmaceutical preparations and products for the treatment of carcinomas and leukaemiaspharmaceutical preparations and products for the treatment of central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer hepatocellular carcinoma and metastatic tumoursenhancers or super-enhancers for medical or clinical usesynthetic super enhancers in gene expression cassettes for medical or clinical useDNA sequences for medical purposespharmaceutical preparations for use in regenerative medicines for treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repairgene therapy pharmaceuticalspharmaceutical preparations being vectorsbiotechnological preparations for medical usebiological compounds for use in the targeted pharmaceutical therapiesproteins with diagnostic and therapeutic useschemical and enzyme preparations for medical or veterinary purposesreagents and substances for use in testing for medical and veterinary purposesdrug delivery agents that facilitate the delivery of pharmaceutical preparationsclinical medical reagentsdiagnostic and testing preparations for clinical, medical and medical laboratory usepharmaceuticals in the field of modulating therapeuticspharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disordersbiological preparations for the treatment of cancerbiological preparations for use in cell cultures for medical purposesdiagnostic biomarker reagents for medical purposescells for medical or clinical useimmune cellstarget antigens for medical usevaccine preparationstherapeutic vaccines
Classe 9
Downloadable computer software programsdownloadable software, namely, lab information management systemscomputer software platformsdownloadable software for remote diagnosticsmachine learning softwaremachine learning software for use in genetic sequencingalgorithms, being computer softwarebioinformatics softwareimaging apparatus and instruments for use in the study of proteins and peptides in drug developmentdata processing softwaredownloadable computer applications in the fields of oncology, recombinant protein production, immunology, cell engineering, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assayssoftware for predicting protein expressionsoftware in the fields of genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, biochemical reagents and biochemical assaysdownloadable computer software for scientific analysis of genetic sequencessoftware algorithms in the fields of biotechnology and modulating therapeuticssoftware as a medical deviceartificial intelligence software in the field of healthcare
Publicações
Histórico de despachos e eventos da marca no INPI.
3 publicações encontradas
IPAS768
Deferimento de designação
RPI 2888
12/05/2026
IPAS756
Publicação de pedido de registro para oposição (exame formal de designação concluído)
RPI 2846
22/07/2025
Marcas relacionadas
Marcas semelhantes
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TGX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o INPI por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.